The PERT Consortium® intends to guide and influence pulmonary embolism (PE) care and research in institutions across the U.S. and will be the driving force behind increased survival rates and the future of PE treatment.
It is the intention of the Consortium to increase awareness of treatment options available to patients with PE, to reduce its incidence worldwide, to improve health outcomes, and to positively influence the impact of this terrible disease.
The National PERT Consortium® is a national alliance of like-minded Pulmonary Embolism Response Teams dedicated to improving care and outcomes for patients with PE.
The collaborative work of the National PERT Consortium® will reduce incidence of PE, improve treatment algorithms, save lives, and reduce the burden of this disease in our patients, our communities, and society overall.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 1, 2022 | Viz.ai Receives Clearance for New Algorithm for Pulmonary Embolism | What You Should Know: Diagnosis and care coordination for patients suffering from PE requires fast multi-disciplinary communication for risk stratification and decision making. Launched in November 2021, Viz PE uses deep learning to identif... |
| How AI is helping to address staffing shortages in healthcare | Healthcare systems are society’s bastion against Covid-19. But two years of working long shifts to cover quarantined colleagues and witnessing patient after patient die of Covid-19 complications has led to massive burnout among frontline he... |
Reviews 0
FAQ about PERT Consortium
What has the press written about PERT Consortium?
Parsers VC has collected 3 articles mentioning PERT Consortium, among them “Viz.ai Receives Clearance for New Algorithm for Pulmonary Embolism” (Sep 1, 2022) and “How AI is helping to address staffing shortages in healthcare”.
Is PERT Consortium still active?
Yes, PERT Consortium is active; its latest activity on Parsers VC dates from Feb 6, 2026.